4-(4-Hydroxy-3-methoxyphenyl)but-3-en-2-one, 98.0%, 10g

tert-butyl 2,2,3,3,5,5,6,6-octadeuteriopiperazine-1-carboxylate, 97, 1g

5-Nitro-2-(trifluoromethyl)benzoic acid, 95.0%, 5g

1-AMINO-2-CYANOPYRROLE, 97.0%, 5g

6-BROMO-2,2-DIMETHYL-4H-BENZO[D][1,3]DIOXINE, 95.0%, 250mg

Isothiazol-5-amine hydrochloride, 95.0%, 50mg

5-Fluoro-3-methyl-1-benzofuran-2-carboxylic acid, 95.0%, 500mg

2-((6-Chloropyridin-2-yl)amino)ethanol, 95.0%, 100mg

5-(Bromomethyl)undecane>97.0%(GC)5g

O-ACETYL-L-SERINE HCL, 95.0%, 1g

E-Plan fase EPLPH objetivo 10x/0,25. Distancia de trabajo 6,61 mm

3-ethylpentane-2,4-dione, 90.0%, 5ml

BENZYL (3-FLUORO-4-THIOMORPHOLINOPHENYL)CARBAMATE, 95.0%, 5g